AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) sank 0.12% to $163.49 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.16% to 3,808.10 and Dow Jones Industrial Average falling 1.02% to 32,930.08. The stock's fall snapped a two-day winning streak. AbbVie Inc. closed $12.42 short of its 52-week high ($175.91), which the company achieved on April 8th.
Despite its losses, the stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.74% to $178.80 and Pfizer Inc. (PFE) fell 0.94% to $49.66. Trading volume (3.5 M) remained 1.9 million below its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 5, 2023.
(END) Dow Jones Newswires
January 05, 2023 16:33 ET (21:33 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.